1. Home
  2. DUOL vs UTHR Comparison

DUOL vs UTHR Comparison

Compare DUOL & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DUOL
  • UTHR
  • Stock Information
  • Founded
  • DUOL 2011
  • UTHR 1996
  • Country
  • DUOL United States
  • UTHR United States
  • Employees
  • DUOL N/A
  • UTHR N/A
  • Industry
  • DUOL Computer Software: Prepackaged Software
  • UTHR Biotechnology: Pharmaceutical Preparations
  • Sector
  • DUOL Technology
  • UTHR Health Care
  • Exchange
  • DUOL Nasdaq
  • UTHR Nasdaq
  • Market Cap
  • DUOL 14.9B
  • UTHR 16.2B
  • IPO Year
  • DUOL 2021
  • UTHR 1999
  • Fundamental
  • Price
  • DUOL $332.81
  • UTHR $357.55
  • Analyst Decision
  • DUOL Buy
  • UTHR Buy
  • Analyst Count
  • DUOL 12
  • UTHR 14
  • Target Price
  • DUOL $361.00
  • UTHR $370.86
  • AVG Volume (30 Days)
  • DUOL 582.5K
  • UTHR 268.9K
  • Earning Date
  • DUOL 11-06-2024
  • UTHR 10-30-2024
  • Dividend Yield
  • DUOL N/A
  • UTHR N/A
  • EPS Growth
  • DUOL N/A
  • UTHR 25.10
  • EPS
  • DUOL 1.83
  • UTHR 22.72
  • Revenue
  • DUOL $689,459,000.00
  • UTHR $2,756,200,000.00
  • Revenue This Year
  • DUOL $42.79
  • UTHR $26.32
  • Revenue Next Year
  • DUOL $29.50
  • UTHR $10.37
  • P/E Ratio
  • DUOL $181.73
  • UTHR $15.73
  • Revenue Growth
  • DUOL 42.47
  • UTHR 25.04
  • 52 Week Low
  • DUOL $145.05
  • UTHR $208.62
  • 52 Week High
  • DUOL $378.48
  • UTHR $417.82
  • Technical
  • Relative Strength Index (RSI)
  • DUOL 46.82
  • UTHR 41.93
  • Support Level
  • DUOL $333.97
  • UTHR $358.82
  • Resistance Level
  • DUOL $360.21
  • UTHR $378.27
  • Average True Range (ATR)
  • DUOL 14.48
  • UTHR 9.60
  • MACD
  • DUOL -4.26
  • UTHR -0.51
  • Stochastic Oscillator
  • DUOL 24.45
  • UTHR 5.07

About DUOL Duolingo Inc.

Duolingo Inc is a technology company that develops mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include The Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has three predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test.

About UTHR United Therapeutics Corporation

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

Share on Social Networks: